. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: Mult Scler. 2020 Jun 25;27(5):674–683. doi: 10.1177/1352458520932804

Table 2.

Counts and volumes of lesions in thalamus.

	All (N = 38)	RRMS (N = 20)	SPMS (N = 18)	p-value^*
Total Thalamic Lesions
Count	1.9 ± 1.5	1.3 ± 0.7	2.6 ± 1.9	0.006
Volume, mm³	99 ± 182	42 ± 46	163 ± 248	0.01
Ovoid Lesions
Count	1.6 ± 1.4	1 ± 0.6	2.3 ± 1.7	0.002
Volume, mm³	74 ± 99	32 ± 28	113 ± 125	0.003
Number of subjects	35	17	18
Periventricular Lesions
Count	0.3 ± 0.5	0.3 ± 0.6	0.2 ± 0.4	0.797
Volume, mm³	133 ± 187	62 ± 50	223 ± 265	0.678
Number of subjects	9	5	4
Venular Lesions
Count	1.5 ± 1.4	1 ± 0.6	2.1 ± 1.7	0.021
Volume, mm³	63 ± 77	28 ± 24	97 ± 96	0.006
Number of subjects	32	16	16
Non-venular Lesions
Count	0.4 ± 0.9	0.4 ± 0.9	0.5 ± 0.8	0.343
Volume, mm³	177 ± 301	100 ± 69	229 ± 391	0.208
Number of subjects	10	4	6

Abbreviations: RRMS = relapsing-remitting multiple sclerosis; SPMS = secondary progressive multiple sclerosis;

for comparisons between RRMS and SPMS subjects; all values are reported as mean ± SD